{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:57:13Z","timestamp":1793721433091,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130461"],"award-info":[{"award-number":["P20GM130461"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130461"],"award-info":[{"award-number":["P20GM130461"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The rising prevalence of fast-acting opioids in the USA suggests the increased need for non-professional first responder administration of naloxone. Effective administration of naloxone during an overdose requires that bystanders are familiar with, have access to, and know how to use naloxone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Drawing on a statewide, address-based sample of Nebraskan adults, we used logistic regression to predict the likelihood of respondents\u2019 familiarity with, access to, and competency to administer naloxone. Our independent variables included measures indicating proximity to drug use, perceived community stigma toward people who use drugs, and demographic data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were significant gaps in naloxone knowledge in Nebraska. Although 74.8% of respondents were familiar with naloxone, only 18.2% knew how to access it and 18.0% knew how to use it. Being close to an overdose experience, lifetime illicit opioid use, being close to a person who uses opioids, and having access to illicit opioids were not significantly associated with naloxone familiarity, access, or competency among respondents in Nebraska\u2019s two largest cities, Omaha and Lincoln. Outside of these cities, being close to a past overdose experience and access to illicit opioids was associated with higher odds of naloxone access and competency, but lifetime opioid use and being close to a person who uses opioids were not. Finally, among those familiar with naloxone, a higher perception of community stigma toward people who use opioids generally was associated with lower odds of naloxone access and competency. Higher perception of community stigma toward people who use heroin, methamphetamines, and cocaine, however, was associated with higher odds of naloxone access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings highlight the continued need for education on naloxone with a specific focus on access and competency to further reduce opioid-related overdose deaths. Specific focus should be placed on promoting naloxone knowledge among people with a higher likelihood of needing to administer naloxone to reduce otherwise avoidable deaths. Further work is needed to understand differences in the relationship between substance-specific perceived stigma and its association with naloxone access.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-024-00954-7","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T23:20:51Z","timestamp":1707520851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey"],"prefix":"10.1186","volume":"21","author":[{"given":"Spencer","family":"Cooper-Ohm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Habecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Humeniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick A.","family":"Bevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"954_CR1","unstructured":"The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 2023;10th edition. AAPOR."},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2014.10.004","volume":"50","author":"TF Borders","year":"2015","unstructured":"Borders TF, Booth BM, Curran GM. African American cocaine users\u2019 preferred treatment site: Variations by rural\/urban residence, stigma, and treatment effectiveness. J Subst Abuse Treatment 2015;50:26\u201331. https:\/\/doi.org\/10.1016\/j.jsat.2014.10.004","journal-title":"J Subst Abuse Treatment"},{"key":"954_CR3","unstructured":"Bureau of Sociological Research. 2022 NASIS Methodology Report. 2022, https:\/\/bosr.unl.edu\/NASIS%2022_Methodology%20Report_Final.pdf"},{"key":"954_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103298","volume":"96","author":"G Burton","year":"2021","unstructured":"Burton G, McAuley A, Schofield J, Yeung A, Matheson C, Parkes T. A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. Int J Drug Policy. 2021;96: 103298. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103298.","journal-title":"Int J Drug Policy"},{"key":"954_CR5","unstructured":"Dohrmann S, Han D, Mohadjer L. Residential address lists vs. traditional listing: Enumerating households and group quarters. In: Proceedings of the section on survey research methods, American Statistical Association, 2006, 2959\u20132964."},{"issue":"5","key":"954_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/poq\/nfl033","volume":"70","author":"RM Groves","year":"2006","unstructured":"Groves RM. Nonresponse rates and nonresponse bias in household surveys. Public Opin Q. 2006;70(5):646\u201375. https:\/\/doi.org\/10.1093\/poq\/nfl033.","journal-title":"Public Opin Q"},{"issue":"6","key":"954_CR7","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/j.amepre.2021.05.042","volume":"61","author":"GP Guy","year":"2021","unstructured":"Guy GP, Khushalani JS, Jackson H, Sims RS, St. C, Arifkhanova A. Trends in state-level pharmacy-based naloxone dispensing rates, 2012\u20132019. Am J Prev Med. 2021;61(6):e289\u201395. https:\/\/doi.org\/10.1016\/j.amepre.2021.05.042.","journal-title":"Am J Prev Med"},{"issue":"6","key":"954_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/pharmacy10060171","volume":"10","author":"LA Hohmann","year":"2022","unstructured":"Hohmann LA, Krauss Z, Patel J, Marley GT. Public perceptions of community pharmacy-based naloxone services: a national cross-sectional survey. Pharmacy. 2022;10(6):171. https:\/\/doi.org\/10.3390\/pharmacy10060171.","journal-title":"Pharmacy"},{"key":"954_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108412","volume":"129","author":"AA Jones","year":"2021","unstructured":"Jones AA, Park JN, Allen ST, Schneider KE, Weir BW, Hunt D, Sherman SG. Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program. J Subst Abuse Treat. 2021;129: 108412. https:\/\/doi.org\/10.1016\/j.jsat.2021.108412.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"954_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","volume":"20","author":"MR Khan","year":"2023","unstructured":"Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR, Townsend TN, Irvine NM, Bennett AS. Racial\/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduct J. 2023;20(1):24. https:\/\/doi.org\/10.1186\/s12954-023-00736-7.","journal-title":"Harm Reduct J"},{"issue":"33","key":"954_CR11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6933a2","volume":"69","author":"BH Lambdin","year":"2020","unstructured":"Lambdin BH, Bluthenthal RN, Wenger LD, Wheeler E, Garner B, Lakosky P, Kral AH. Overdose education and naloxone distribution within syringe service programs\u2014United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1117\u201321. https:\/\/doi.org\/10.15585\/mmwr.mm6933a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"954_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/poq\/nfn003","volume":"72","author":"MW Link","year":"2008","unstructured":"Link MW, Battaglia MP, Frankel MR, Osborn L, Mokdad AH. A Comparison of address-based sampling (ABS) versus random-digit dialing (RDD) for general population surveys. Public Opin Q. 2008;72(1):6\u201327. https:\/\/doi.org\/10.1093\/poq\/nfn003.","journal-title":"Public Opin Q"},{"key":"954_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108912","volume":"227","author":"L Lipira","year":"2021","unstructured":"Lipira L, Leichtling G, Cook RR, Leahy JM, Orellana ER, Korthuis PT, Menza TW. Predictors of having naloxone in urban and rural Oregon findings from NHBS and the OR-HOPE study. Drug Alcohol Depend. 2021;227: 108912. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108912.","journal-title":"Drug Alcohol Depend"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00127-015-1122-2","volume":"51","author":"SE McCabe","year":"2015","unstructured":"McCabe SE, West BT. Selective nonresponse bias in population-based survey estimates of drug use behaviors in the United States. Soc Psychiatry Psychiatr Epidemiol. 2015;51:141\u201353. https:\/\/doi.org\/10.1007\/s00127-015-1122-2.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"954_CR15","unstructured":"Nebraska LB390\u2014Provide for medical use of cannabidiol and naloxone and change controlled substances schedules and transfers to the Nebraska Health Care Cash Fund. (2015). Nebraska Revised Statute 28-442 (2017)."},{"issue":"4","key":"954_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11013-016-9496-5","volume":"40","author":"J Netherland","year":"2016","unstructured":"Netherland J, Hansen HB. The war on drugs that wasn\u2019t: wasted whiteness, \u201cdirty doctors\u201d, and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664\u201386. https:\/\/doi.org\/10.1007\/s11013-016-9496-5.","journal-title":"Cult Med Psychiatry"},{"key":"954_CR17","unstructured":"O\u2019Muircheartaigh C, English E, Eckman S. Predicting the relative quality of alternative sampling frames. In: Proceedings of the Section on Survey Research Methods, American Statistical Association, 2007;551\u201374."},{"key":"954_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2018.04.004.","journal-title":"Int J Drug Policy"},{"key":"954_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.drugpo.2019.07.010","volume":"73","author":"M Reed","year":"2019","unstructured":"Reed M, Wagner KD, Tran NK, Brady KA, Shinefeld J, Roth A. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs. Int J Drug Policy. 2019;73:32\u20135. https:\/\/doi.org\/10.1016\/j.drugpo.2019.07.010.","journal-title":"Int J Drug Policy"},{"key":"954_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00606-8","volume-title":"Harm reduction in the Heartland: Public knowledge and beliefs about naloxone in Nebraska","author":"A Schlosser","year":"2022","unstructured":"Schlosser A, Habecker P, Bevins R. Harm reduction in the Heartland: Public knowledge and beliefs about naloxone in Nebraska. USA: Harm Reduction Journal; 2022. https:\/\/doi.org\/10.1186\/s12954-022-00606-8."},{"issue":"1","key":"954_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12954-021-00466-8","volume":"18","author":"KE Schneider","year":"2021","unstructured":"Schneider KE, Urquhart GJ, Rouhani S, Park JN, Morris M, Allen ST, Sherman SG. Practical implications of naloxone knowledge among suburban people who use opioids. Harm Reduct J. 2021;18(1):47. https:\/\/doi.org\/10.1186\/s12954-021-00466-8.","journal-title":"Harm Reduct J"},{"key":"954_CR22","unstructured":"Stop Overdose Nebraska (2023) Participating pharmacies. https:\/\/stopodne.com\/see-all-narcan-pharmacies\/"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"108878","DOI":"10.1016\/j.drugalcdep.2021.108878","volume":"226","author":"HL Surratt","year":"2019","unstructured":"Surratt HL, Otachi JK, McLouth CJ, Vundi N. Healthcare stigma and HIV risk among rural people who inject drugs. Drug Alcohol Depend 2021;226:108878. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108878.","journal-title":"Drug Alcohol Depend"},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","volume":"59","author":"K Tobin","year":"2018","unstructured":"Tobin K, Clyde C, Davey-Rothwell M, Latkin C. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018;59:94\u20137. https:\/\/doi.org\/10.1016\/j.drugpo.2018.07.003.","journal-title":"Int J Drug Policy"},{"key":"954_CR25","unstructured":"U.S. Census Bureau. Population Estimates, July 1, 2022 (V2022) \u2013 Nebraska.\u00a0Quick Facts. 2022, https:\/\/www.census.gov\/quickfacts\/fact\/table\/wallawallacitywashington,US\/"},{"issue":"23","key":"954_CR26","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014. Morbidity Mortality Weekly Report 2015;64(23):631\u20135.","journal-title":"Morbidity Mortality Weekly Report"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsat.2019.01.005","volume":"99","author":"LH Yang","year":"2019","unstructured":"Yang LH, Grivel MM, Anderson B, Bailey GL, Opler M, Wong LY, Stein MD. A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: evidence for construct validity. J Subst Abuse Treat. 2019;99:44\u201351. https:\/\/doi.org\/10.1016\/j.jsat.2019.01.005.","journal-title":"J Subst Abuse Treat"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-00954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-00954-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-00954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T23:22:13Z","timestamp":1707520933000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-00954-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-00954-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3536993\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Nebraska Lincoln Institutional Review Board approved this research (#20160816236FB]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}